Wert202020212022202320242025TTMMittelzufluss aus Investitionstätigkeit-331.46 M-205.19 M330.34 M168.5 M137.62 M-132.21 M-147.53 MZahlungsströme aus der Finanzierungstätigkeit500.85 M576.19 M482.64 M254.46 M30.2 M47.46 M50.67 MFreier Cashflow-182.51 M-335.24 M-431.5 M-246.96 M135.66 M76.11 M104.51 M
Natera, Inc. - Common Stock
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.